Introducing Sympfiny®
A Next Generation Multiparticulate Delivery System
Sympfiny® is an innovative oral delivery system for dosing and dispensing dry powder, microsphere, and multiparticulate drug formulations.
Sympfiny® is an innovative oral delivery system for dosing and dispensing dry powder, microsphere, and multiparticulate drug formulations.
Sympfiny’s breakthrough system enables caregivers to store, extract, and deliver dry drugs with the same familiarity used with traditional liquid oral drugs. The patent pending design allows easily controlled precise dispensing, ensuring all medication is delivered in the child’s mouth.
Sympfiny can be used in a wide variety of settings and by a diverse set of users. Sympfiny was designed with the entire supply chain in mind. The system’s bottle can be pre-filled or pharmacy filled. The internal valve and bottle cap design ensure the drug is protected through shipment, storage and use. The re-usable syringe comes in two sizes with both offering adjustable dose settings.
The benefits of multiparticulates and Sympfiny include:
To better understand Sympfiny and how it works, download the instructions for use here: Sympfiny Instructions for Use (1.0MB PDF)
Sympfiny® can be customized for a wide variety of drugs and doses.
Oral multiparticulate technology, in the form of beads, mini-tablets and microspheres with coated and/or matrix architecture, offers a wide range of drug release profile flexibility for single or multiple drug combinations. They can be formulated as modified-release (e.g. extended, delayed, pulsed), immediate-release, bioavailability-enhanced, or taste-masked dosage forms.
In addition, multiparticulates provide predictable and consistent gastrointestinal transit and lower chances of undesirable events (e.g., dose dumping, colonic streaming) associated with tablets. These multiparticulates can be dosed within capsules, tablets (microspheres, coated beads) or sachets.
The benefits of multiparticulates include:
“Almost three million children die needlessly each year from pneumonia and diarrhea alone.
The treatment of choice for pneumonia – amoxicillin – appears to be available in developing countries, however critically, not in the recommended dose and formulation.”
— The Pathway to Better Medicines for Children (2011)
HS Design has over 40 years experience in pharmaceutical drug delivery design and is a recognized leader in the pharmaceutical delivery field with expertise in Human Factors, User Expereience, Design, and Engineering. HSD’s user-centered design perspective coupled with engineering expertise provides high quality with a consumer focus.
Röchling Medical develops and produces pharmaceutical primary packaging solutions and delivery systems. Röchling employs cutting-edge technology in its products and production facilities to ensure superior, cost effective solutions for their customers worldwide. Our high-quality products offer customers exceptional pharmaceutical hygiene, reliability, and application safety.
HS Design and Röchling’s strategic partnership brings a unique advantage for developing first-of-kind devices, and create Sympfiny. Everything we do for and with our customers is done by motivated and qualified specialists at our local organizations. These individuals are accessible globally and cooperate closely for creating the highest value for our customers.
United States Contact:
HSD Ventures
906 Mt. Kemble Ave
Morristown, NJ 07960
Visit us at Booth 4 on September 10 – 12 in Malmö, Sweden.
Apr
10-12
Join HS Design and Röchling this April at the Pharmintech Exhibition taking place in Bologna, Italy.
May
15-16
Join HS Design and Röchling at the Boston Convention & Exhibition Center this May.